NICE on u/s-guided foam sclerotherapy:
This article was originally published in Clinica
The UK National Institute for Health and Clinical Excellence (NICE) has deemed ultrasound-guided foam sclerotherapy to be effective in treating varicose veins in the short term. In an update of the interventional procedures (IP) guidance it issued on the technique in June 2006, NICE notes "transient side effects in a small proportion of patients", thereby requiring special arrangements for consent and audit/research. The guidance has been endorsed by NHS Quality Improvement Scotland, making it valid for the whole of the UK. However, IP appraisals do not assess clinical demand for the procedure - nor have they any legal weight - so provide no indication of their impact on the use of the technologies involved. The "special arrangements" attached to NICE's decisions on interventional procedures are the subject of an open consultation.
You may also be interested in...
Teva plans to begin appeal proceedings, the firm has told Generics Bulletin, after being fined €60.5m ($72m) by the European Commission over an historic “pay-for-delay” arrangement covering subsidiary firm Cephalon’s Provigil (modafinil).
SK set for Korean trial with vaccine, as Biological E begins human trials of Baylor vaccine. Meanwhile, DongWha gets a Phase II nod for potential drug, and Celltrion progesses with Phase II regdanvimab trial.
UK start up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country.